蛋白质的乳酸修饰在瘤进展中起着至关重要的作用
Dehao Yi1, Ke Zhou1, Yinlong Pan1
1Department of Emergency, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Frontiers in oncology
|April 7, 2025
概括
乳化是一种新的蛋白质修饰,在癌症中将新陈代谢和表观遗传学联系在一起. 这篇评论探讨了它在瘤生长,免疫逃避和耐药性方面的作用,提供了新的治疗点.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 乳化是一种新发现的蛋白质转化后修饰 (PTM).
- 它弥合了细胞代谢重编程和表观遗传调节.
- 乳化与瘤生物学的各个方面有关,包括生长,血管新生,侵袭和转移.
研究的目的:
- 审查关于瘤中乳化修饰的最新研究.
- 专注于乳化在瘤血管生成中的机制,瘤微环境 (TME) 内的免疫细胞调节,以及药物耐药性.
- 为癌症治疗中的新型治疗目标和策略提供理论基础和研究想法.
主要方法:
- 关于癌症中乳化最近研究的文献综述.
- 对乳化作用背后的分子机制的分析.
- 与血管新生,TME和耐药性相关的发现的综合.
主要成果:
- 乳化会影响瘤血管生成,侵袭和转移.
- 它调节了TME内的免疫细胞表型和两极分化.
- 乳化通过多种途径促进瘤耐药性的发展.
结论:
- 乳化是瘤进展和治疗耐药性的关键因素.
- 了解乳化机制可以揭示新的治疗点.
- 向乳化可能提供克服耐药性和改善临床结果的策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Covalently Linked Protein Regulators
6.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.7K
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K


